Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Kidney cancer: targeting FGF for third-line treatment of mRCC.

Literature DB >> 24595120

Kidney cancer: targeting FGF for third-line treatment of mRCC.

Sarah Payton.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2014 PMID： 24595120 DOI： 10.1038/nrurol.2014.55

Source DB: PubMed Journal: Nat Rev Urol ISSN： 1759-4812 Impact factor: 14.432

Keyword Cloud
References

× No keyword cloud information.

1 in total

1. Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trial.

Authors: Robert J Motzer; Camillo Porta; Nicholas J Vogelzang; Cora N Sternberg; Cezary Szczylik; Jakub Zolnierek; Christian Kollmannsberger; Sun Young Rha; Georg A Bjarnason; Bohuslav Melichar; Ugo De Giorgi; Viktor Grünwald; Ian D Davis; Jae-Lyun Lee; Emilio Esteban; Gladys Urbanowitz; Can Cai; Matthew Squires; Mahtab Marker; Michael M Shi; Bernard Escudier
Journal: Lancet Oncol Date: 2014-02-17 Impact factor: 41.316

1 in total